ClinicalTrials HQ

Montefiore Einstein Cancer Center

Montefiore Einstein Cancer Center

The Bronx, New York, United States

7 results · Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate CancerMetastatic Castration-Resistant Prostate CancerRecruitingPhase 22026-10-08NCT07287150
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-PositiveHER2-positive Breast CancerRecruitingPhase 2 / Phase 32026-10-06NCT07413939
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 1 / Phase 22026-10-06NCT07100106
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 32026-10-06NCT06793215
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid TumorsSolid TumorRecruitingPhase 12026-09-23NCT06619587
First in Human, Dose Escalation Study of AN4005Advanced Lymphoma; Advanced Solid TumorRecruitingPhase 12025-11-18NCT04999384
Leading in MPNs Beyond Ruxolitinib in Combo With T-RegsHemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, blood platelet disease, bone marrow disorder, bone marrow neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, primary myelofibrosis, thrombocytosis diseaseRecruitingPhase 12025-04-13NCT05423691